Search
Alaunos Therapeutics Inc
TCRTAdd to Watchlist
2.080USD
-0.080-3.70%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
4.89MMarket Cap
LossP/E TTM
More Details of Alaunos Therapeutics Inc Company
Alaunos Therapeutics, Inc. is a pre-clinical obesity and metabolic disorder and clinical-stage oncology-focused cell therapy company. The Company focuses on developing small molecules that are expected to be efficacious against obesity and other metabolic disorders. The Company is engaged in developing novel small molecule-based obesity therapeutics. The Company’s operations consist primarily of conducting research and development and raising capital to fund those efforts. The Company has not generated any revenues.
Alaunos Therapeutics Inc Info
Ticker SymbolTCRT
Company nameAlaunos Therapeutics Inc
IPO dateAug 20, 2004
CEOWeis (Holger)
Number of employees1
Security typeOrdinary Share
Fiscal year-endAug 20
Address501 E Las Olas Blvd
CityFORT LAUDERDALE
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code33301
Phone13463554099
Websitehttps://alaunos.com/
Ticker SymbolTCRT
IPO dateAug 20, 2004
CEOWeis (Holger)
Company Executives of Alaunos Therapeutics Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Holger Weis, CPA
Mr. Holger Weis, CPA
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
12.67K
+61.25%
Mr. Ferdinand Groenewald
Mr. Ferdinand Groenewald
Vice President - Finance
Vice President - Finance
10.78K
--
Mr. Jaime W. Vieser
Mr. Jaime W. Vieser
Independent Director
Independent Director
--
--
Mr. Robert W. Postma
Mr. Robert W. Postma
Independent Director
Independent Director
--
--
Mr. Michael Jerman
Mr. Michael Jerman
Director
Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Holger Weis, CPA
Mr. Holger Weis, CPA
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
12.67K
+61.25%
Mr. Ferdinand Groenewald
Mr. Ferdinand Groenewald
Vice President - Finance
Vice President - Finance
10.78K
--
Mr. Jaime W. Vieser
Mr. Jaime W. Vieser
Independent Director
Independent Director
--
--
Mr. Robert W. Postma
Mr. Robert W. Postma
Independent Director
Independent Director
--
--
Mr. Michael Jerman
Mr. Michael Jerman
Director
Director
--
--
FAQs
Who are the top five shareholders of Alaunos Therapeutics Inc?
The top five shareholders of Alaunos Therapeutics Inc are: Mr. Holger Weis, CPA
How many institutions hold shares of Alaunos Therapeutics Inc (TCRT)?
As of 2026Q1, 83 institutions hold shares of Alaunos Therapeutics Inc, with a combined market value of approximately 172.58K, accounting for 7.48% of the total shares. Compared to 2025Q4, institutional shareholding has increased by -19883.00.